Skip to main content
. 2019 May 31;39(5):BSR20190754. doi: 10.1042/BSR20190754

Figure 2. FEZF1-AS1 overexpression is associated with unfavorable prognosis in retinoblastoma patients.

Figure 2

The relationship between FEZF1-AS1 expression and DFS was evaluated through Kaplan–Meier method and log-rank test.